Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan ; volume:16 ; number:1 ; day:29 ; month:7 ; year:2016 ; pages:1-8 ; date:12.2016
BMC gastroenterology ; 16, Heft 1 (29.7.2016), 1-8, 12.2016
- Urheber
-
Takeshima, Fuminao
- Beteiligte Personen und Organisationen
-
Yoshikawa, Daisuke
Higashi, Syuntaro
Morisaki, Tomohito
Oda, Hidetoshi
Ikeda, Maho
Machida, Haruhisa
Matsushima, Kayoko
Minami, Hitomi
Akazawa, Yuko
Yamaguchi, Naoyuki
Ohnita, Ken
Isomoto, Hajime
Ueno, Masato
Nakao, Kazuhiko
SpringerLink (Online service)
- DOI
-
10.1186/s12876-016-0501-9
- URN
-
urn:nbn:de:1111-201607315356
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Takeshima, Fuminao
- Yoshikawa, Daisuke
- Higashi, Syuntaro
- Morisaki, Tomohito
- Oda, Hidetoshi
- Ikeda, Maho
- Machida, Haruhisa
- Matsushima, Kayoko
- Minami, Hitomi
- Akazawa, Yuko
- Yamaguchi, Naoyuki
- Ohnita, Ken
- Isomoto, Hajime
- Ueno, Masato
- Nakao, Kazuhiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Duodenal Crohn’s disease successfully treated with adalimumab
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Crohn’s appendicitis
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
Esophageal Crohn’s disease
Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Duodenal Crohn’s disease successfully treated with adalimumab
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Crohn’s appendicitis
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
Esophageal Crohn’s disease
Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
A Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn’s Disease Treated with Adalimumab or Infliximab
Duodenal Crohn’s disease successfully treated with adalimumab
Leukocytoclastic Vasculitis Associated with Adalimumab Therapy for Crohn’s Disease
Listeria Monocytogenes Brain Abscess in Crohn’s Disease Treated with Adalimumab
Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis
Distal esophageal involvement in Crohn disease: short treatment with adalimumab
Crohn’s appendicitis
Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies
Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn’s Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment
Esophageal Crohn’s disease
Prospective study of an adalimumab combined with partial enteral nutrition in the induction period of Crohn’s disease
Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease